Particularly important hazard of false-negative results obtainment can take place in tumor samples, e.g., in screening for epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer (NSCLC) patients or in clinical virology [8, 9]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.